SCHEMBL17751

SCHEMBL17751

CC(O)(c1ccc(N2CCN(S(=O)(=O)C3=CC=CCC3=S)C[C@H]2CN2CCOCC2)cc1)C(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 8/20 0.57
GCK P35557 12/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16117 1.00 GCKR (0.57) GCKRGCK
SCHEMBL16515 1.00 GCKR (0.57) GCKRGCK
SCHEMBL12078956 1.00 GCKR (0.57) GCKRGCK
SCHEMBL12079089 1.00 GCKR (0.57) GCKRGCK
SCHEMBL12078898 1.00 GCKR (0.57) GCKRGCK
SCHEMBL12079119 1.00 GCKR (0.57) GCKRGCK
SCHEMBL23764 0.92 GCK (0.54) GCKRGCK
SCHEMBL12078970 0.92 GCK (0.54) GCKRGCK
SCHEMBL23625 0.92 GCK (0.54) GCKRGCK
SCHEMBL12079772 0.91 GCK (0.50) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed